# FDA recall D-1069-2023

> **Central Admixture Pharmacy Services Inc** · Class II · drug recall initiated 2023-07-17.

## Product

fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, 250 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2081-1

## Reason for recall

Lack of assurance of sterility: Lack of validation data for sanitization cycles

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-1069-2023
- **Recalling firm:** Central Admixture Pharmacy Services Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-07-17
- **Report date:** 2023-08-09
- **Termination date:** 2025-03-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** San Diego, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1069-2023

## Citation

> AI Analytics. FDA recall D-1069-2023. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-1069-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*